Evaluating the Impact of Basic Needs Assessment and Support to Improve Colposcopy Show Rates: The BASICS Trial

This randomized controlled, single-site study hopes to determine the effectiveness of a tailored phone call reminder to improve low-income patients' adherence to colposcopy.

Study Overview

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female

    -≥ 21 years of age

  • English speaking
  • Able to provide verbal consent

Exclusion Criteria:

  • Male
  • Incarcerated
  • Unable to consent
  • Does not have access to a working contact phone number

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Arm 1: Basic Needs Assessment
-Patients will receive a phone call from a research team member 2-4 weeks before their colposcopy appointment. The team member will remind the patient of the date and time of their appointment and conduct a basic needs assessment. Those who have at least one unmet basic need or are unsure of their current needs will be referred to the 24-hr assistance hotline, 2-1-1 United Healthy Way Missouri. After the date of their appointment, patients will be contacted to ask whether they contacted 2-1-1 and used any recommended services.
This federally funded, free service connects callers with appropriate community services to help address their unmet basic needs.
Study participants will be asked to rate the amount of distress that they have experienced in the past week (scale of 0 to 10, 10=extreme distress) and indicate areas of concern including practical basic needs and family, emotional, spiritual, and physical problems. They will also be asked to rate the amount of distress (scale 0-10) that they attribute to their abnormal cervical cancer screen.
11-item survey with questions regarding safety, housing, food, and financial needs
This brief, 5-minute survey will be performed either in person or by phone after the participants arrive to their colposcopy appointment or after 6 weeks of their scheduled visit if they are nonadherent. The research team will ask patients regarding any changes in the status of their unmet basic needs (resolved, improved, worsened, or stayed the same) and how useful they found the 2-1-1 resource.
Active Comparator: Arm 2: Usual Care Cohort
-Patients will receive an automated phone call two weeks before their colposcopy appointment to remind them of the date and time of their visit.
-Automated phone call two weeks before their colposcopy appointment

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Adherence to colposcopy visit
Time Frame: Within 6 weeks of study enrollment
Within 6 weeks of study enrollment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number and type of unmet basic needs as measured by Unmet Basic Needs Survey
Time Frame: At the time of enrollment; at least 2 weeks prior to colposcopy appointment
-Questions asking participant about food security, housing, personal safety, neighborhood safety, sufficient money for necessities, childcare, and transportation. Scored bases on participant' self-perceived likelihood that their safety, housing, food, and financial needs would be met in the next month.
At the time of enrollment; at least 2 weeks prior to colposcopy appointment
General distress scores as measured by NCCN Distress Thermometer
Time Frame: At the time of enrollment
-Participant is asked to circle the number from 0-10 that best describes how much distress the participant has experienced in the past week. 0=no distress and 10=extreme distress.
At the time of enrollment
Causes of distress as measured by NCCN Distress Problem List
Time Frame: At the time of enrollment
-39 questions asking participant to answer yes or no to problems (practical, family, emotional, spiritual/religious, and physical) that they have experienced in the past week
At the time of enrollment
Distress scores related to indications for colposcopy
Time Frame: At the time of enrollment
-Score 0 (no distress) to 10 (severe distress)
At the time of enrollment
Patient self-reported use of 2-1-1 services as measured by 2-1-1 Survey
Time Frame: After or within 1 week after colposcopy visit (estimated to be 6 weeks)
After or within 1 week after colposcopy visit (estimated to be 6 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Lindsay M Kuroki, M.D., MSCI, Washington University School of Medicine

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

May 31, 2022

Primary Completion (Anticipated)

May 31, 2023

Study Completion (Anticipated)

May 31, 2023

Study Registration Dates

First Submitted

January 7, 2021

First Submitted That Met QC Criteria

January 7, 2021

First Posted (Actual)

January 11, 2021

Study Record Updates

Last Update Posted (Actual)

June 29, 2022

Last Update Submitted That Met QC Criteria

June 22, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 202010144

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Colposcopy

Clinical Trials on 2-1-1 United Way Healthy Missouri Hotline

3
Subscribe